Autoimmune hypoglycemia expands the biological spectrum of HHV8(+) multicentric Castleman disease

Autoimmune hypoglycemia belongs to the clinical spectrum of HHV8(+) MCD and rituximab is an effective treatment of this condition. This rare complication is related to autoantibodies directed toward the insulin receptor and activating the insulin signaling pathway.

Salvato in:
Dettagli Bibliografici
Pubblicato in:Blood Adv
Autori principali: Arnautou, Pierre, Auclair, Martine, Fellahi, Soraya, Bouché, Clara, Fieschi, Claire, Barrak, Elias, Queyrel-Moranne, Viviane, Chaillous, Lucy, Blin, Nicolas, Malphettes, Marion, Fadlallah, Jehane, Bertinchamp, Remi, Gérard, Laurence, Bengoufa, Djaouida, Galicier, Lionel, Oksenhendler, Eric, Vigouroux, Corinne, Boutboul, David
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2021
Soggetti:
Stimulus Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8045508/
https://ncbi.nlm.nih.gov/pubmed/33787862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002801
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi